Header Logo

Shiyoung Roh

Concepts (71)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Telemedicine
6
2024
344
0.830
 Why?
Glaucoma, Open-Angle
6
2023
49
0.790
 Why?
Glaucoma
4
2023
60
0.710
 Why?
Intraocular Pressure
7
2023
73
0.570
 Why?
Diabetic Retinopathy
3
2024
51
0.560
 Why?
Macular Degeneration
2
2024
187
0.320
 Why?
Product Packaging
1
2008
4
0.280
 Why?
Hyphema
1
2008
3
0.280
 Why?
Eye Injuries
1
2008
14
0.280
 Why?
Diabetes Mellitus
2
2023
541
0.260
 Why?
Wounds, Nonpenetrating
1
2008
117
0.260
 Why?
Patient Portals
1
2024
51
0.210
 Why?
Visual Acuity
3
2024
125
0.210
 Why?
Geographic Atrophy
1
2024
19
0.210
 Why?
Wet Macular Degeneration
1
2023
22
0.200
 Why?
Ophthalmology
1
2022
24
0.180
 Why?
Smartphone
1
2021
71
0.160
 Why?
Dark Adaptation
1
2019
8
0.150
 Why?
Follow-Up Studies
4
2024
2478
0.110
 Why?
Humans
15
2024
64244
0.100
 Why?
Pandemics
3
2023
676
0.100
 Why?
Intravitreal Injections
2
2024
48
0.100
 Why?
Optic Nerve
2
2023
25
0.090
 Why?
Patient Compliance
2
2024
362
0.090
 Why?
Anterior Chamber
1
2008
4
0.070
 Why?
Antihypertensive Agents
2
2007
172
0.070
 Why?
Phacoemulsification
1
2007
8
0.070
 Why?
Trabeculectomy
1
2007
9
0.070
 Why?
Cataract
1
2007
54
0.070
 Why?
Prostaglandins F, Synthetic
1
2006
1
0.060
 Why?
Amides
1
2006
56
0.060
 Why?
Cross-Sectional Studies
2
2021
2616
0.050
 Why?
Lipids
1
2006
319
0.050
 Why?
Telephone
1
2023
122
0.050
 Why?
Appointments and Schedules
1
2023
60
0.050
 Why?
Ranibizumab
1
2021
19
0.040
 Why?
Receptors, Vascular Endothelial Growth Factor
1
2021
33
0.040
 Why?
Nerve Fibers
1
2021
30
0.040
 Why?
Retinal Ganglion Cells
1
2021
31
0.040
 Why?
Bevacizumab
1
2021
58
0.040
 Why?
Female
5
2024
33351
0.040
 Why?
Diagnostic Techniques, Ophthalmological
1
2021
11
0.040
 Why?
Angiogenesis Inhibitors
1
2021
76
0.040
 Why?
Photography
1
2021
41
0.040
 Why?
Retina
1
2021
126
0.040
 Why?
Aged
4
2024
14648
0.040
 Why?
Recombinant Fusion Proteins
1
2021
495
0.040
 Why?
Retrospective Studies
2
2021
6726
0.040
 Why?
Visual Fields
1
2019
49
0.040
 Why?
Disease Progression
1
2023
1176
0.040
 Why?
Tomography, Optical Coherence
1
2021
215
0.040
 Why?
Referral and Consultation
1
2021
428
0.030
 Why?
Patient Satisfaction
1
2021
438
0.030
 Why?
Middle Aged
3
2024
17899
0.030
 Why?
Adolescent
1
2008
6304
0.030
 Why?
Prospective Studies
2
2019
3315
0.030
 Why?
Pilot Projects
1
2019
1019
0.030
 Why?
Male
4
2024
30295
0.030
 Why?
Reproducibility of Results
1
2019
1681
0.030
 Why?
Aged, 80 and over
2
2019
5520
0.030
 Why?
Risk Factors
1
2022
5339
0.020
 Why?
Surveys and Questionnaires
1
2019
2737
0.020
 Why?
Tonometry, Ocular
1
2007
20
0.020
 Why?
Lens Implantation, Intraocular
1
2007
8
0.020
 Why?
Mitomycin
1
2007
26
0.020
 Why?
Bimatoprost
1
2006
1
0.020
 Why?
Cloprostenol
1
2006
1
0.020
 Why?
Ophthalmic Solutions
1
2006
8
0.020
 Why?
Double-Blind Method
1
2006
744
0.010
 Why?
Circadian Rhythm
1
2006
387
0.010
 Why?
Adult
1
2019
17117
0.010
 Why?
Roh's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (71)
Explore
_
Co-Authors (4)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_